Delivery Order SPE2DR25D2007-SPE2DR26FM09D
Award Date 11/5/25
Potential Completion Date 11/6/25
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,562.51 on September 18, 2025, for the supply of Emgality 300 mg (100 mg x3 syringe/mL) under a Defense Logistics Agency Medical Supply Chain contract. The award is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 19, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single task against...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,729.00 by the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Emgality 120 mg/mL pen injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,729.00 by the Defense Logistics Agency on August 26, 2025, for the supply of Emgality 120 mg/ml pen injections. This is a firm fixed price, non-set-aside contract with a completion date of August 27, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the pharmaceutical product Emgality 120 mg/mL pen on May 20, 2025, with a ceiling value of $1,037.40. This firm fixed-price contract is non-competitive and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through December 2026. The place of performance is...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,036.60 by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Emgality 120 mg/ml syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 22, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 10, 2025, for the supply of Emgality 120 mg/ml pens, a migraine treatment medication. This competitively awarded, non-set-aside contract has a ceiling value of $1,037.40 with a firm fixed price structure and an ultimate completion date of September 11, 2025. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,547.00 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Emgality 300 mg (100 mg x 3 syringe/ml). This competitively awarded, firm fixed-price delivery order is non-set-aside and is scheduled for completion by August 26, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively solicited delivery order valued at $8,299.20 on April 25, 2025, for the supply of Emgality 120mg/ml injectable medication. This firm fixed-price delivery order, which is scheduled for completion by May 22, 2025, falls under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical designated as SPE2DX, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,401.40 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen (injectable migraine treatment) with a completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The contract specifies performance at the company's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a delivery order valued at $3,309.37 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pen injectors. This firm fixed price, competitively awarded contract was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...